المؤلفون: Ugur Ozbek, Leyla Agaoglu, Sema Anak, Inci Yildiz, Omer Devecioglu, Sema Sirma, Cetin Timur, Adalet Meral, Gunduz Gedikoglu, Lebriz Yüksel

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Anabilim Dalı., Meral, Adalet, U-6138-2017, C-9513-2017

المصدر: Journal of pediatric hematology/oncology. 25(3)

مصطلحات موضوعية: Oncology, Male, Pathology, Unclassified drug, Oncogene Proteins, Fusion, Turkey, TEL-AML1, Cryptic t(12-21), Hybrid protein, Chromosomal translocation, Childhood leukemia, Acute lymphoblastic leukemia, Pediatrics, Fusion gene, Acute Lymphoblastic Leukemia, Chromosome 21, Pre B Lymphocyte, Turkey (republic), hemic and lymphatic diseases, Pediatric leukemia, Relapse, Child, Children, Priority journal, Hematology, Incidence (epidemiology), Precursor Cell Lymphoblastic Leukemia-Lymphoma, Transcript, Prognosis, Reverse transcription polymerase chain reaction, Survival Rate, Child, Preschool, Core Binding Factor Alpha 2 Subunit, Female, Reciprocal chromosome translocation, Human, medicine.medical_specialty, Adolescent, Major clinical study, Article, Immunophenotyping, Acute lymphocytic leukemia, Internal medicine, Tel aml1 protein, medicine, Humans, neoplasms, business.industry, Infant, Newborn, Infant, Pre b lymphocyte, Frequency, medicine.disease, Childhood, Fusion protein, Subgroup, Clinical feature, Fusion transcript, Pediatrics, Perinatology and Child Health, Kaplan meier method, Leukemia, lymphocytic, acute, business, TEL/AML1 fusion, Cancer incidence

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5b2022e23daaa34e9a3aadafec85188
https://pubmed.ncbi.nlm.nih.gov/12621238